What does CUSIP 98420N105 represent in this 13F holders report?

CUSIP 98420N105 is the security identifier for XENE - Xenon Pharmaceuticals Inc. - Common Shares used to aggregate holder disclosures.

How many institutions held XENE - Xenon Pharmaceuticals Inc. - Common Shares in Q2 2018?

41 institutional investors reported XENE - Xenon Pharmaceuticals Inc. - Common Shares for Q2 2018. Use the holders table for investor-level position and value details.

Xenon Pharmaceuticals Inc. - Common Shares (XENE)

CUSIP: 98420N105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Shares
Shares outstanding: 92,799,600
Total 13F shares: 9,038,748
Share change: +2,752,566
Total reported value: $83,159,306
Price per share: $9.20
Number of holders: 41
Value change: +$29,134,581
Number of buys: 21
Number of sells: 14

Security key

98420N105

Report period

Q2 2018

Institutions

Top holders

XENE full security history Newer quarter: Q3 2018 Previous quarter: Q1 2018 Xenon Pharmaceuticals Inc. SEC filings Xenon Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 98420N105

Newer quarter: Q3 2018 Previous quarter: Q1 2018

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital World Investors	13F	Company	1.5%	1,429,000	$7,002,000	—	31 Mar 2018	13F
BVF INC/IL	13F	Company	0.78%	720,830	$3,532,000	—	31 Mar 2018	13F
ORBIMED ADVISORS LLC	13F	Company	0.68%	634,812	$3,111,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.41%	385,000	$1,887,000	—	31 Mar 2018	13F
NEXTHERA CAPITAL LP	13F	Company	0.41%	379,071	$1,857,000	—	31 Mar 2018	13F
DAFNA Capital Management LLC	13F	Company	0.41%	377,695	$1,851,000	—	31 Mar 2018	13F
Invesco Private Capital, Inc.	13F	Company	0.37%	341,884	$1,675,000	—	31 Mar 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.33%	307,079	$1,505,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.31%	288,000	$1,411,000	—	31 Mar 2018	13F
Tekla Capital Management LLC	13F	Company	0.3%	280,000	$1,372,000	—	31 Mar 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.27%	247,057	$1,211,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	0.16%	150,000	$735,000	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0.13%	116,692	$572,000	—	31 Mar 2018	13F
David M. Knott	13F	Individual	0.12%	114,900	$563,000	—	31 Mar 2018	13F
K2 PRINCIPAL FUND, L.P.	13F	Company	0.11%	101,103	$495,000	—	31 Mar 2018	13F
SABBY MANAGEMENT, LLC	13F	Company	0.07%	67,000	$328,000	—	31 Mar 2018	13F
State of New Jersey Common Pension Fund D	13F	Company	0.07%	65,000	$319,000	—	31 Mar 2018	13F
SCOTIA CAPITAL INC.	13F	Company	0.07%	64,357	$315,000	—	31 Mar 2018	13F
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	13F	Company	0.07%	62,875	$308,000	—	31 Mar 2018	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.06%	55,000	$270,000	—	31 Mar 2018	13F
DRW Securities, LLC	13F	Company	0.03%	30,000	$147,000	—	31 Mar 2018	13F
NJ State Employees Deferred Compensation Plan	13F	Company	0.02%	20,000	$98,000	—	31 Mar 2018	13F
Elmwood Wealth Management, Inc.	13F	Company	0.02%	18,729	$91,772	—	31 Mar 2018	13F
Leith Wheeler Investment Counsel Ltd.	13F	Company	0.02%	16,075	$79,000	—	31 Mar 2018	13F
RBF Capital, LLC	13F	Company	0.02%	15,100	$73,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.01%	12,700	$62,000	—	31 Mar 2018	13F
STIFEL FINANCIAL CORP	13F	Company	0.01%	11,875	$58,000	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.01%	11,120	$54,000	—	31 Mar 2018	13F
OppenheimerFunds, Inc.	13F	Company	0.01%	11,005	$54,000	—	31 Mar 2018	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	0.01%	8,293	$23,000	—	31 Mar 2018	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	3,280	$16,000	—	31 Mar 2018	13F
Cubist Systematic Strategies, LLC	13F	Company	0%	2,200	$11,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0%	1,657	$8,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0%	700	$3,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	450	$2,000	—	31 Mar 2018	13F

Institutional Holders of Xenon Pharmaceuticals Inc. - Common Shares (XENE) as of Q2 2018

As of 30 Jun 2018, Xenon Pharmaceuticals Inc. - Common Shares (XENE) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,038,748 shares. The largest 10 holders included Capital World Investors, venBio Select Advisor LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Granite Point Capital Management, L.P., Schonfeld Strategic Advisors LLC, ACUTA CAPITAL PARTNERS, LLC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 41 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.